The V Foundation for Cancer Research and CVC Partner to Accelerate Breast Cancer Vaccines

The V Foundation for Cancer Research and the Cancer Vaccine Coalition (CVC) have launched a first-of-its-kind partnership to speed the development of therapeutic breast cancer vaccines. In this ONCOLife exclusive interview, we speak with Susanna Greer, PhD, Chief Scientific Officer at the V Foundation for Cancer Research, about how this collaboration is driving innovation and advancing the future of breast cancer care. You can follow this interview on LinkedIn by this link:>>>

Join us as we explore the V Foundation’s bold efforts to advance cancer research and their vision for funding early-phase clinical trials through “Game-Changer Grants” — a pivotal step in bringing precision vaccines from the bench to the bedside.

Some of the key topics in this interview include:

• What is the vision behind the partnership between the V Foundation and the Cancer Vaccine Coalition to accelerate breast cancer vaccines?
• What role does the V Foundation play in advancing early-phase cancer research through initiatives like “Game-Changer Grants”?
• How is this collaboration helping to speed clinical trials and improve access for patients?
• What are the biggest scientific and logistical challenges in developing cancer vaccines — and how can they be overcome?
• How does this partnership reflect a broader shift toward precision medicine and survivorship in oncology?